166 related articles for article (PubMed ID: 35137609)
1. Protective effects of necrostatin-1 on doxorubicin-induced cardiotoxicity in rat heart.
Erdogmus Ozgen Z; Erdinc M; Kelle İ; Erdinc L; Nergiz Y
Hum Exp Toxicol; 2022; 41():9603271211066066. PubMed ID: 35137609
[No Abstract] [Full Text] [Related]
2. Necrostatin-1 accelerates time to death in a rat model of cecal ligation and puncture and massively increases hepatocyte caspase-3 cleavage.
Zhang Q; Wei S; Lu J; Fu W; Chen H; Huang Q; Chen Z; Zeng Z
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G551-G561. PubMed ID: 30735454
[TBL] [Abstract][Full Text] [Related]
3. Acetylcholinesterase inhibitor ameliorates doxorubicin-induced cardiotoxicity through reducing RIP1-mediated necroptosis.
Khuanjing T; Ongnok B; Maneechote C; Siri-Angkul N; Prathumsap N; Arinno A; Chunchai T; Arunsak B; Chattipakorn SC; Chattipakorn N
Pharmacol Res; 2021 Nov; 173():105882. PubMed ID: 34530122
[TBL] [Abstract][Full Text] [Related]
4. Necrostatin-1 Protects Against Paraquat-Induced Cardiac Contractile Dysfunction via RIP1-RIP3-MLKL-Dependent Necroptosis Pathway.
Zhang L; Feng Q; Wang T
Cardiovasc Toxicol; 2018 Aug; 18(4):346-355. PubMed ID: 29299822
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of paracetamol in doxorubicin-induced cardiotoxicity in ischemia/reperfused isolated rat heart.
Hesari M; Shackebaei D; Asadmobini A
Anatol J Cardiol; 2018 Feb; 19(2):94-99. PubMed ID: 29350208
[TBL] [Abstract][Full Text] [Related]
6. Necrostatin-1 Synergizes the Pan Caspase Inhibitor to Attenuate Lung Injury Induced by Ischemia Reperfusion in Rats.
Wang L; Chen B; Xiong X; Chen S; Jin L; Zhu M
Mediators Inflamm; 2020; 2020():7059304. PubMed ID: 33162831
[TBL] [Abstract][Full Text] [Related]
7. Combination of necroptosis and apoptosis inhibition enhances cardioprotection against myocardial ischemia-reperfusion injury.
Koshinuma S; Miyamae M; Kaneda K; Kotani J; Figueredo VM
J Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24113863
[TBL] [Abstract][Full Text] [Related]
8. Phosphocreatine attenuates doxorubicin-induced cardiotoxicity by inhibiting oxidative stress and activating TAK1 to promote myocardial survival in vivo and in vitro.
Wang C; Hu L; Guo S; Yao Q; Liu X; Zhang B; Meng X; Yang X
Toxicology; 2021 Aug; 460():152881. PubMed ID: 34358621
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective Effects of Necrostatin-1 Against Oxidative Stress-Induced Cell Damage: an Involvement of Cathepsin D Inhibition.
Jantas D; Chwastek J; Grygier B; Lasoń W
Neurotox Res; 2020 Mar; 37(3):525-542. PubMed ID: 31960265
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
[TBL] [Abstract][Full Text] [Related]
11. Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative stress and preventing mitochondrial dysfunction mediated by 14-3-3γ.
He H; Luo Y; Qiao Y; Zhang Z; Yin D; Yao J; You J; He M
Food Funct; 2018 Aug; 9(8):4404-4418. PubMed ID: 30063064
[TBL] [Abstract][Full Text] [Related]
12. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
Zhang QL; Yang JJ; Zhang HS
Biomed Pharmacother; 2019 Jan; 109():71-83. PubMed ID: 30396094
[TBL] [Abstract][Full Text] [Related]
13. In Vivo and In Vitro Protective Effects of Rosmarinic Acid against Doxorubicin-Induced Cardiotoxicity.
Rahbardar MG; Eisvand F; Rameshrad M; Razavi BM; Hosseinzadeh H
Nutr Cancer; 2022; 74(2):747-760. PubMed ID: 34085575
[TBL] [Abstract][Full Text] [Related]
14. Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.
Lee KH; Cho H; Lee S; Woo JS; Cho BH; Kang JH; Jeong YM; Cheng XW; Kim W
Int J Cardiol; 2017 Apr; 232():40-47. PubMed ID: 28159361
[TBL] [Abstract][Full Text] [Related]
15. Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart.
Chicco AJ; Schneider CM; Hayward R
Am J Physiol Regul Integr Comp Physiol; 2005 Aug; 289(2):R424-R431. PubMed ID: 15845878
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of Di'ao Xinxuekang capsule against doxorubicin-induced chronic cardiotoxicity.
Li X; Liang J; Qin A; Wang T; Liu S; Li W; Yuan C; Qu L; Zou W
J Ethnopharmacol; 2022 Apr; 287():114943. PubMed ID: 34954266
[TBL] [Abstract][Full Text] [Related]
17. Pleiotropic, non-cell death-associated effects of inhibitors of receptor-interacting protein kinase 1 in the heart.
Horvath C; Szobi A; Kindernay L; Ravingerova T; Adameova A
Mol Cell Biochem; 2021 Aug; 476(8):3079-3087. PubMed ID: 33811579
[TBL] [Abstract][Full Text] [Related]
18. GSK2795039 prevents RIP1-RIP3-MLKL-mediated cardiomyocyte necroptosis in doxorubicin-induced heart failure through inhibition of NADPH oxidase-derived oxidative stress.
Zhang XJ; Li L; Wang AL; Guo HX; Zhao HP; Chi RF; Xu HY; Yang LG; Li B; Qin FZ; Wang JP
Toxicol Appl Pharmacol; 2023 Mar; 463():116412. PubMed ID: 36764612
[TBL] [Abstract][Full Text] [Related]
19. Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes.
Yu X; Ruan Y; Huang X; Dou L; Lan M; Cui J; Chen B; Gong H; Wang Q; Yan M; Sun S; Qiu Q; Zhang X; Man Y; Tang W; Li J; Shen T
Biochem Biophys Res Commun; 2020 Feb; 523(1):140-146. PubMed ID: 31837803
[TBL] [Abstract][Full Text] [Related]
20. Human Amnion Membrane Proteins Prevent Doxorubicin-Induced Oxidative Stress Injury and Apoptosis in Rat H9c2 Cardiomyocytes.
Faridvand Y; Haddadi P; Vahedian V; Nozari S; Nejabati HR; Pezeshkian M; Afrasiabi A; Safaie N; Jodati A; Nouri M
Cardiovasc Toxicol; 2020 Aug; 20(4):370-379. PubMed ID: 32086724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
